Exemption number (b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.Based on the information provided, the reported difficulties were due to procedural circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that this was a peripheral percutaneous intervention treating the bilateral iliac arteries, moderately calcified lesions.Two omnilink elite stents were successfully placed.Imaging was performed with an unspecified catheter, when the catheter snagged the left iliac, 8x39mm omnilink elite stent.The stent was dragged down to the bifurcation at the common femoral with imaging catheter removal.The same imaging catheter was used to push the stent back to the desired implantation site.The stent was successfully re-expanded and was implanted at the desired location.There was no stent damage observed, however, as a precaution, another stent was successfully implanted, overlapping the 8x39mm omnilink elite stent.Reportedly, the procedure ended with good results noted.There was no adverse patient sequela and there was no clinically significant delay.No additional information was provided regarding this issue.
|